Leptospirosis: Spirochete with more than 200 "serovars."
• Agent
o Spirochete with more than 200 "serovars." The pathogenic serovars do not replicate outside animal hosts
• Leptospira interrogans
• Serovars: autumnalis, bratislava, canicola, icterohaemorrhagiae, pomona
• Leptospira kirshneri
• Serovar: gryppotyphosa
• Leptospira borgpetersenii
• Serovar: hardjo
o Specific serovars are "hosted-adapted" to certain reservoir species and generally do not cause disease in those hosts, e.g.:
• L. interrogans bratislava pigs, rats, small mammals
• L. interrogans canicola dogs
• L. interrogans icterohaemorrhagiae rats
• L. kirschneri grippotyphosa voles, raccoons, small mammals
• Epidemiology
o Animals are critical to the maintenance of pathogenic leptospires in a given area.
o Leptospires can persist in the renal tubules without causing disease, and can be excreted in the urine for prolonged periods of time.
• Leptospires evade immune responses while sequestered in renal tubules.
o Prevalence in dogs is increasing since 1983
• Risk factors
• Adult (4 – 7 years) intact male dogs
• Herding, working dogs, and hounds
o Enzootic worldwide
• Tropical and semitropical areas
• Alkaline soil
• Leptospires can survive in moist environments for months, but are killed by freezing
o Seasonality
• Summer or fall
• Rainy periods
• Transmission
o Leptospires are eliminated by urine and enter the body through abraded skin and intact mucous membranes
o In dogs, leptospira concentrates in the liver and kidneys
• Clinical signs – 7 days post-exposure
• May clear the infection in 2 – 3 weeks
• May develop chronic renal failure or chronic active hepatitis
o In cats, infections are usually subclinical
• Cats can shed leptospira in the environment
• Clinical Signs
o Many, if not most, Leptospira infections in dogs are subclinical
o L. interrogans icterohaemorrhagiae: Hepatic disease and hemorrhage occur mostly with (may also have sub-acute uremia)
o L. interrogans bratislava: Renal disease predominates with (liver changes also can be present)
o L. interrogans pomona: Renal and liver disease mostly
o L. kirschneri grippotyphosa: Renal and liver disease mostly
o L. interrogans canicola: Mostly renal changes
o Experimental infection
• L. interrogans pomona and L. interrogans bratislava causes hemorrhagic and inflammatory lesions in lungs kidneys and liver.
o Signs
• Fever
• Uveitis
• Vomiting, diarrhea
• Renal failure
• Liver failure
• Jaundice
• Muscle pain
• Laboratory Abnormalities
o CBC
• Leukopenia (acute)
• Leukocytosis (subacute)
• Thrombocytopenia
o Renal failure
• Increased BUN and creatinine
• Cillindruria
• Pyuria
• Hematuria
o Liver disease
• Increased activity of ALT and Alkaline phosphatase
• ALP is usually higher than ALT
• Increased bilirubin
o Interstitial lung disease
• Diagnosis
o Clinical Signs + Serology
• Detection of antibodies
• Antibodies from active infection, previous infection or vaccination
• Active infection
o MAT titer > 3200
o 4 fold increase in titer over 2 – 4 weeks
o Positive IgM ELISA
o Titers can be negative in acute infection
o Vaccine may induce antibodies against L. interrogans automnalis
• Demonstration of the organism
• Dark-field or phase-contrast microscopy in the urine
o Intermittent shedding leads to false-negative
• Culture
o Before antibiotics
o Place immediately in transport media
o To the laboratory ASAP
o Pre-treatment with furosemide may increase yield
• PCR (urine)
o Early positive
o Very sensitive
o May be positive for years after recovery
o 8% of dogs (regardless of health status) shed pathogenic leptospir
o Serology is a poor predictor of leptospiruria
• 22% sensitivity, 79% specificity
• Therapy
o Fluid therapy
• Maintain hydration
• Preserve renal function
o Antibiotics
• Ampicillin or penicillin G
• Initially IV
• Doxycycline for 2 weeks after penicillin to eliminate the carrier phase
• Decreases shedding, but may not eliminate it
• Prevention
o All serovars can potentially infect humans
o Wear gloves
o Vaccines
• Can reduce severity of the disease but do not eliminate the carrier state
• May not protect against all serovars
• Not necessary in geographic areas with low/absent risk
• The most reactogenic vaccines for the dog
• The duration of immunity is short (≤ 1 year).
• If risk of Leptospira disease is high
• Vaccines need to be given much more often than they are currently given
• 4-way lepto product
• 12 weeks, 15 weeks, 6 months, 1 year
• Then every 6 to 9 months if it remains at high risk
• Relative efficacy
• L. interrogans canicola: ≤ 75%
• L. kirshnerii grippotyphosa: ≤ 60%
• L. interrogans icterohaemorrhagiae: ≤ 90%
• L. interrogans pomoma: ≤ 60%
• Public health
o Leptospirosis can occur as either sporadic cases or in epidemics
o Infection occurs through mucosal contact with water or soil contaminated with the urine of infected animals
o Risk occupations
• Veterinarians, farmers and abattoir workers
• Recreational activities in water
Adin CA & Cowgill LD. Treatment and outcome of dogs with leptsopirosis: 36 cases. JAVMA 216():371-5, 2000.
Bal AE et al. Detection of leptropires in urine by PCR for early diagnosis of leptospirosis. J Clin Microbiol 32(8):1894-8, 1994
Barr, S.C. et al. Serologic responses of dogs given a comme rcial vaccine against Leptospira interrogans serovar pomona and Leptospira kirschn eri serovar grippotyphosa. AJVR. 66:1780-1874. 2005
Birnbaum N et al. Naturally acquired leptospirosis in 36 dogs: serological and clinicopathological features. JSAP 39(5):231-6, 1998
Brown CA et al. Leptospira interrogans serovar grippotyphosa infection in dogs. JAVMA 209(7):1265-7, 1995.
Forrest, L.J. et al. Sonographic renal finding s in 20 dog s with leptospirosis. Vet. Radiol. Ultrasound 39:337-340. 1998
Greenlee , J.J. et al. Clinical and pathologic comparison of acute leptospirosis in dogs caused by two strains of Leptospira kirschneri serovar grippotyphosa. AJVR. 65:1100-1107. 2004
Greenlee JJ. Experimental canine leptospirosis caused by Leptsopira interrogans serovars pomona or bratislava. AJVR 66(10):1816-22, 2005
Harkin KR & Gartrell CL. Canine leptospirosis in New Jersey and Michigan: 17 cases (1990-1995). JAAHA 32(6):495-501, 1996.
Harkin, K.R. et al. Clinical application of a polymerase chain reaction assay for diagnosis of leptospirosis in dogs. JAVMA. 222:1224-1229. 2003
Harkin, K.R. et al. Comparison of polymerase chain reaction assay, bacteriologic culture, and serologic testing in assessment of prevalence of urinary shedding of leptospires in dogs. JAVMA. 222:1230-1233. 2003
Levett, P.N. Leptospirosis. Clin. Microbiol. Rev. 14:296-326. 2001
Ward, M.P. et al. Evaluation of environmental risk factors for leptospirosis in dogs: 36 cases (1997-2002). JAVMA. 225:72-77. 2004
Ward, M.P. et al. Prevalence of and risk factors for leptospirosis among dogs in the United States and Canada: 677 cases (1970-1998). JAVMA. 220:53-58. 2002
Ward, M.P. et al. Serovar-specific prevalence and risk factors for leptospirosis among dogs: 90 cases (1997- 2002). J.VMA. 224:1958-1963. 2004
UN, WHO address public health concern over avian flu transmission to humans
April 18th 2024Veterinary professionals working with certain animals are advised to take precautionary steps to minimize risk of infection, while researchers in Texas study potential H5N1 vaccines, antivirals, and antibody therapies for humans
Read More